FDA product code NZC: Stent, Urethral, Prostatic, Semi-Permanent

NZC is the FDA product code for stent, urethral, prostatic, semi-permanent. It is a Class III device, reviewed by the Gastroenterology and Urology panel. Devices under NZC reach the market by PMA; FDA lists no cleared 510(k)s for it. 1 PMA application cites this product code.

Definition

Approximately 3 cm tube placed in the prostatic urethra for short term use to drain urine. The device includes a retention mechanism that anchors in the bladder neck to hold it in place and a release mechanism that exits the penis. For short term use in men with partial of full prostatic urethral obstruction or the prevention of prostatic urethral obstruction post surgery or other prostatic treatment.

Classification

FieldValue
Device nameStent, Urethral, Prostatic, Semi-Permanent
Device classClass III
Review panelGU — Gastroenterology and Urology
Medical specialtyUnknown
Premarket routePMA

Recalls for NZC devices

FDA recall records list no recalls for product code NZC.

Frequently asked questions

What is FDA product code NZC?

NZC is the FDA product code for stent, urethral, prostatic, semi-permanent. It is a Class III device, reviewed by the Gastroenterology and Urology panel.

What device class is NZC?

Class III. Typical premarket route: PMA.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Gastroenterology and Urology product codes · FDA product code lookup · 510(k) database search · 510(k) review times